Table 1.
Clinical isolates from lepromatous ulcers and their antibiogram *
| Serial no. | Name of organism | No. of isolates | Antibiotic susceptibility | ||||||
|---|---|---|---|---|---|---|---|---|---|
| A | G | Ak | Cf | Pf | Ca | Ce | |||
| 1 | S. aureus | 16 (25·00) | 04 (25·00) | 10 (62·5) | 12 (75·00) | 11 (68·75) | 10 (62·5) | 10 (62·5) | 09 (56·25) |
| 2 | Klebsiella spp. | 15 (23·43) | 02 (13·33) | 07 (46·66) | 11 (73·33) | 09 (60·00) | 09 (60·00) | 10 (66·66) | 08 (53·33) |
| 3 | E. coli | 08 (12·5) | 02 (25·00) | 04 (50·00) | 06 (75·00) | 05 (62·5) | 05 (62·5) | 07 (87·5) | 03 (37·5) |
| 4 | Streptococci | 07 (10·93) | 05 (71·42) | 04 (57·14) | 04 (57·14) | 05 (71·42) | 05 (71·42) | 03 (42·85) | 04 (57·14) |
| 5 | P. aeruginosa | 07 (10·93) | 00 (42·85) | 03 (57·14) | 04 (57·14) | 04 (42·85) | 03 (71·42) | 05 (42·85) | 03 (57·14) |
| 6 | Staphylococus albus | 06 (9·37) | 03 (50·00) | 03 (50·00) | 03 (50·00) | 06 (100) | 06 (100) | 03 (50·00) | 03 (50·00) |
| 7 | Citrobacter spp. | 05 (7·81) | 01 (20·00) | 03 (60·00) | 04 (80·00) | 03 (60·00) | 02 (40·00) | 04 (80·00) | 02 (40·00) |
| Total | 64 | 17 (26·56) | 34 (53·12) | 44 (68·75) | 43 (67·18) | 40 (62·5) | 42 (65·62) | 32 (50·00) | |
A, ampicillin; Ak, amikacin; Ca, ceftazidime; Ce, ceftriaxone; Cf, ciprofloxacin; G, gentamicin; Pf, pefloxacin.
*Figures in parentheses indicate percentage.